Authors
Guanidinosuccinic acid (GSA) has been isolated in substantial quantities from the urine of uremic patients (1). Attempts to form this compound by transamidination from canavanine and arginine to aspartic acid were unsuccessful. A possible pathway has been found for GSA formation. Human liver homogenate splits canavaninosuccinic acid (CSA) to form homoserine and GSA. Optimum pH is at 8.7-8.8. The reaction proceeds best under anaerobic conditions. Reduced lipoic acid must be present for the reaction. NADH, NADPH, GSH, cysteine, ascorbic acid, NaCN, Fe++, and reduced CoA, dithiothreitol, and BAL cannot be substituted for the lipoic acid. BAL, NADH, NADPH, Fe++, and Co++ act as inhibitors for the reaction. A nondialyzable inhibitor also is present in the liver and can be washed out with water. More than 90% of GSA incubated with various tissues and administered subcutaneously to intact rats was recovered unchanged. It is suggested that GSA is an end product of metabolism in the human.
No takes yet. Share an insight, caveat, or question.
Takahara et al. (1969) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: